Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Milky Way Investments: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Milky Way Investments
Milky Way Investments
Active
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 1, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Jan 8, 2026
Parabilis Medicines
$305.0M Series F
Jake Simson
Catalio Capital Management
,
Foresite Capital
,
ARCH Venture Partners
,
Cormorant Asset Management
,
Farallon Capital Management
, Frazier Life Sciences
,
Freepoint Capital Group
,
General Catalyst
, HBM Healthcare Investments
,
Invus
,
Marshall Wace
,
Nextech Invest
,
Rock Springs Capital
,
Sixty Degree Capital
,
Soleus Capital
, T. Rowe Price Associates
Feb 1, 2024
FogPharma
$150.0M Series E
Thilo Schroeder
Lux Capital
,
Nextech Invest
,
The Column Group
,
venBio
, Alex Gorsky
,
ARCH Venture Partners
,
Catalio Capital Management
,
Cormorant Asset Management
,
Farallon Capital Management
, Fidelity Management & Research Company
,
Foresite Capital
,
General Catalyst
, Google Ventures
,
Invus
,
Marshall Wace
, RA Capital Management
,
Rock Springs Capital
,
Samsara BioCapital
,
Sixty Degree Capital
, SymBiosis
, T. Rowe Price Associates
Nov 1, 2022
FogPharma
$180.0M Series D
—
Nextech Invest
,
venBio
,
ARCH Venture Partners
,
Casdin Capital
,
Cormorant Asset Management
,
Deerfield Management
,
Farallon Capital Management
, Fidelity Management & Research Company
, Google Ventures
, HBM Healthcare Investments
,
Invus
,
PagsGroup
, T. Rowe Price Associates
Jan 7, 2021
LifeMine Therapeutics
$50.0M Series B
Richard Klausner
,
Milky Way Investments
ARCH Venture Partners
,
Blue Pool Capital
,
Foresite Capital
, Google Ventures
,
MRL Ventures Fund
,
WuXi Healthcare Ventures
Mar 18, 2020
Cero Therapeutics
$40.0M Series A
—
Altitude Life Science Ventures
, Robert Nelsen
, Hongshan Capital Group (Sequoia Capital China)
, Richard Klausner